Search for: "Deas v. Deas" Results 1 - 20 of 821
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Dec 2015, 3:36 pm by Sabrina I. Pacifici
EFF – “A Victory for Privacy and Transparency: HRW v. [read post]
7 Aug 2023, 8:40 am by Delia A. Deschaine
” Helpfully, DEA is asking those who plan to attend the listening sessions to consider the following questions ahead of time: If telemedicine prescribing of schedule III-V medications were permitted in the absence of an in-person medical evaluation, what framework, including safeguards and data, with respect to telemedicine prescribing of schedule III-V medications do you recommend to help the agency ensure patient safety and prevent diversion of controlled… [read post]
8 Apr 2015, 7:04 am by Nate Cardozo
  Related Issues: InternationalSurveillance and Human RightsPrivacyRelated Cases: HRW v. [read post]
23 Jun 2012, 7:03 pm by W.F. Casey Ebsary, Jr.
Marijuana, versus Prescription Drugs, versus Meth, versus Heroin, versus Cocaine  DEA Chief grilled on impact of Marijuana, versus Prescription Drugs, versus Meth, versus Heroin, versus Cocaine. [read post]
14 Dec 2015, 12:21 pm by Mark Rumold
          Files: defendants_responses_to_plaintiffs_interrogatories_1-5.pdfletter_from_kathryn_wyer_to_mark_rumold.pdfRelated Issues: PrivacyRelated Cases: HRW v. [read post]
8 Oct 2010, 9:11 am by FDABlog HPM
An agent may telephone a pharmacy concerning a prescription for a controlled substance in schedules III through V and convey the practitioner’s otherwise valid oral prescription provided the prescriber has specified all required prescription information. 3. [read post]
21 Aug 2008, 12:51 pm
A former DEA special agent denied a promotion will receive a new trial on her Title VII race, sex and retaliation claims because the district court improperly restricted the introduction of evidence regarding a separate, ongoing race discrimination action against the DEA in which the plaintiff was class member, the Fourth Circuit held yesterday in Buckley v. [read post]
31 Mar 2023, 9:31 am by Aaron Black
Here, a telehealth practitioner may prescribe up to a 30-day supply of a schedule III-V non-narcotic controlled medication. [read post]
7 Mar 2023, 7:14 am by Alan J. Arville
Notably, the proposed rules also give DEA-registered practitioners who have relied on the DEA’s emergency waiver—which, since January 2020, has allowed practitioners to prescribe Schedules II-V controlled substances without conducting a prior in-person medical evaluation of the patient—up to 180 days to come into compliance with the new in-person evaluation requirements that would be implemented in the final regulations. [read post]